Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
AstraZeneca
Sotio Biotech Inc.
PMV Pharmaceuticals, Inc
BeOne Medicines
Monte Rosa Therapeutics, Inc
Neonc Technologies, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tasca Therapeutics
MacroGenics
MacroGenics
ImmunityBio, Inc.
Hoffmann-La Roche
DualityBio Inc.
Incyte Corporation
Janux Therapeutics
Novelty Nobility, Inc.
Hangzhou DAC Biotechnology Co., Ltd.
Pfizer
Incyte Corporation
A2 Biotherapeutics Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
TransThera Sciences (Nanjing), Inc.
OncoC4, Inc.
Klus Pharma Inc.
Theratechnologies
Cofactor Genomics, Inc.
Seagen Inc.
Cybrexa Therapeutics
Carisma Therapeutics Inc
Travera Inc
23andMe, Inc.
AstraZeneca
Salubris Biotherapeutics Inc
Merck Sharp & Dohme LLC
Pfizer
Xencor, Inc.
TransThera Sciences (Nanjing), Inc.
Exelixis
HiberCell, Inc.
Evopoint Biosciences Inc.
Fate Therapeutics
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Incyte Corporation
Hoffmann-La Roche